Press Releases Lucid Diagnostics Inc.

Equities

LUCD

US54948X1090

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
0.9159 ^USD	-1.52%		+1.20%	-35.04%

May. 13	Transcript : Lucid Diagnostics Inc., Q1 2024 Earnings Call, May 13, 2024
May. 13	Lucid Diagnostics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PAVmed Provides Business Update and First Quarter 2024 Financial Results	May. 13	PR
Lucid Diagnostics : Corporate Presentation - March 2024	Apr. 03	PU
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results	Mar. 26	PR
Lucid Diagnostics Provides Update Regarding World Trade Center Health Program	Feb. 19	AQ
Lucid Diagnostics Executes Contract to Provide EsoGuard Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors	Feb. 09	AQ
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies	Dec. 12	PR
PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2023	Nov. 01	PR
Lucid Diagnostics : Private Placement - Form 8-K	23-10-18	PU
PAVmed and Lucid Diagnostics to Participate in Panel Presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference	23-09-21	PR
Lucid Diagnostics Releases Positive Data Demonstrating Clinical Utility of EsoGuard Esophageal Precancer Detection in Fire Fighters	23-09-07	AQ
Lucid Diagnostics Releases Positive Data Demonstrating Clinical Utility of EsoGuard® Esophageal Precancer Detection in Fire Fighters	23-09-06	PR
Exploring 4 Penny Stocks That Just Made Headlines (EPAZ, AMBL, DFCO, PAVM)	23-09-01	AQ
CapitalGainsReport: 4 Penny Stocks That Just Made Big Headlines (EPAZ, AMBL, DFCO, PAVM)	23-09-01	AQ
Lucid Diagnostics Executes First Direct Employer Contract to Provide EsoGuard Esophageal Precancer Testing as an Employee Benefit	23-08-25	AQ
PAVmed to Hold a Business Update Conference Call and Webcast on August 16, 2023	23-07-31	PR
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 15, 2023	23-07-31	PR
PAVmed Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement	23-06-28	PR
PAVmed to Participate in Healthcare Virtual Conference Presented by Maxim Group LLC	23-06-14	PR
PAVmed Digital Health Subsidiary, Veris Health, Joins Cancer Moonshot's CancerX Partnership as Founding Member	23-06-05	AQ
PAVmed Digital Health Subsidiary, Veris Health, Joins Cancer Moonshot's CancerX Partnership as Founding Member	23-06-02	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Lucid Diagnostics Inc.

Equities

LUCD

US54948X1090

Press Releases

Filters